You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Nanoparticles are being tested as potential drug delivery devices for a number of different treatments, but recent research from scientists at the Norwegian Radium Hospital shows that they may, in some cases, hinder cellular function, reports Forbes' Alex Knapp.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.